The Illinois Opioid bill is actually significant. (Industry, nationwide)
We've been doing more and more an enormous amount of work there.
Illinois is actually essentially a mirror of NJ. Lacking med program held back by anti Gov. Opioid Bill went through with impressive results and headed for Gov's desk. (He will probably veto), but already veto proof vote, with next session to override November, at which time Pritzker will probably win, who, similar to Murphy, has taken an extremely firm stance on cannabis (medical as well as recreational), even campaigning on "IL needs a cannabis Governor, and I'm your guy".
The adult use bill is also under development (3rd largest market in nation) and, again, similar to NJ, they are biding their time per se to introduce once new Governor is in office. (Whom has already committed to signing it).
While it is stated "thousands" of patients for Opioid Bill, it is more likely an additional market of hundreds of thousands. (Estimates of 200-400k) The bill also removes most of the current restrictions on patients (fingerprinting and background checks) and make sit a "same day" process from Dr. to shopping, as opposed to a wait period currently up to about 100 days.
So the nation and industry is looking at (2018) NY, NJ, IL, MI, MA and possibly AZ adult use and I believe OK, UT, MO? medical, as well as Pete Sessions possibly ousted in November.
2018 much more significant than 2016.
News 
Market Data 
Discover 
